NASDAQ:OTLK - Outlook Therapeutics Price Target & Analyst Ratings

$1.75
0.00 (0.00 %)
(As of 09/15/2019 04:00 PM ET)
Today's Range
$1.7004
Now: $1.75
$1.82
50-Day Range
$1.35
MA: $1.88
$2.35
52-Week Range
$0.85
Now: $1.75
$10.96
Volume293,854 shs
Average Volume474,710 shs
Market Capitalization$49.40 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.64

Analyst Ratings

Outlook Therapeutics (NASDAQ:OTLK) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
5 Wall Street analysts have issued ratings and price targets for Outlook Therapeutics in the last 12 months. Their average twelve-month price target is $9.00, suggesting that the stock has a possible upside of 414.29%. The high price target for OTLK is $12.00 and the low price target for OTLK is $4.00. There are currently 5 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 3.003.003.00N/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $9.00$9.00$9.3333N/A
Price Target Upside: 414.29% upside361.54% upside586.27% upsideN/A

Outlook Therapeutics (NASDAQ:OTLK) Consensus Price Target History

Outlook Therapeutics (NASDAQ:OTLK) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/11/2019LADENBURG THALM/SH SHInitiated CoverageBuy$9.00High
7/18/2019HC WainwrightInitiated CoverageBuy$8.00High
5/16/2019CIBCInitiated CoverageOutperform ➝ Outperform$12.00High
5/16/2019OppenheimerInitiated CoverageOutperform$12.00 ➝ $12.00High
4/22/2019Ascendiant Capital MarketsInitiated CoverageBuy ➝ Buy$4.00High
(Data available from 9/15/2017 forward)
This page was last updated on 9/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel